Latham, Fenwick Steer Up To $400M Deal For Biotech Modis
Drugmaker Zogenix Inc. has agreed to pay as much as $400 million to absorb privately held biotech Modis Therapeutics Inc., the companies said Monday, in a deal guided by Latham &...To view the full article, register now.
Already a subscriber? Click here to view full article